Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CENPI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCDC88A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFADN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WWC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105374768 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CISH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01616 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929441 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SREBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OMD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01096 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on